CTOR

Citius Oncology
CTOR

0.8300 USD
+0.0499
6.4%
At close Updated Apr 15, 4:00 PM EDT
Pre-market
After hours
0.8200
-0.0100
1.2%
1 day
6.4%
5 days
31.87%
1 month
2.99%
3 months
-23.15%
6 months
-51.74%
Year to date
-23.15%
1 year
21.52%
5 years
-91.77%
10 years
-91.77%
 

About: Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.

Healthcare Drug Manufacturers - Specialty & Generic
0
Funds holding %
of 8,116 funds
Explore Fund Trends
–
Analysts bullish %
See Analyst Outlook
–
Positive news %
Check Journalist POV
Price charts implemented using Lightweight Charts™